From that experience, Apprentice was born-a next-generation, cloud-based, all-in-one solution for life sciences manufacturing that enables streamlined, collaborative, and flexible processes. Angelo founded the company in 2014, inspired by his wife who experienced the difficulties of navigating the archaic processes firsthand while working in pharmaceutical manufacturing. When we first met Angelo Stracquatanio, Apprentice’s CEO, and co-founder, we were immediately captivated by his enthusiasm and passion to tackle this growing problem in modern pharma manufacturing. ![]() Apprentice aims to change all that, and that’s why we’re excited to be leading their $65M funding round alongside our friends at Alkeon Capital and Insight Partners. These challenges are magnified by a manufacturing process that has traditionally relied on manual, paper-based processes or legacy systems, making it extremely difficult for companies to adapt their on-premises systems to meet the requirements to produce these new drugs. But while innovative therapeutics in biologics and cell and gene therapies have tremendous potential, they’re also meaningfully more complex and costly to manufacture compared to traditional small molecule drugs. The pharmaceutical industry has made incredible strides in recent years to develop developing life-changing therapeutics for many diseases, offering new hope to patients and their families.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |